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The sources of shockwave generation include electrohydraulic, electromagnetic and piezoelectric principles.
Electrohydraulic shockwaves are high-energy acoustic waves generated under water explosion with high voltage
electrode. Shockwave in urology (lithotripsy) is primarily used to disintegrate urolithiasis, whereas shockwave in
orthopedics (orthotripsy) is not used to disintegrate tissues, rather to induce tissue repair and regeneration. The
application of extracorporeal shockwave therapy (ESWT) in musculoskeletal disorders has been around for more
than a decade and is primarily used in the treatment of sports related over-use tendinopathies such as proximal
plantar fasciitis of the heel, lateral epicondylitis of the elbow, calcific or non-calcific tendonitis of the shoulder and
patellar tendinopathy etc. The success rate ranged from 65% to 91%, and the complications were low and
negligible. ESWT is also utilized in the treatment of non-union of long bone fracture, avascular necrosis of femoral
head, chronic diabetic and non-diabetic ulcers and ischemic heart disease. The vast majority of the published
papers showed positive and beneficial effects. FDA (USA) first approved ESWT for the treatment of proximal plantar
fasciitis in 2000 and lateral epicondylitis in 2002. ESWT is a novel non-invasive therapeutic modality without surgery
or surgical risks, and the clinical application of ESWT steadily increases over the years. This article reviews the
current status of ESWT in musculoskeletal disorders.
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Extracorporeal shockwave therapy (ESWT) began with an
incidental observation of osteoblastic response pattern
during animal studies in the mid-1980 that generated an
interest in the application of ESWT to musculoskeletal
disorders. In the past 10 to 15 years, shockwave therapy
had emerged as the leading choice in the treatment of
many orthopedic disorders including proximal plantar fas-
ciitis of the heel [1-6], lateral epicondylitis of the elbow
[7-10], calcific tendinitis of the shoulder [11,12] and. non-
union of long bone fracture [13-15]. More recently, the
use of ESWT had expanded to the treatment of patellar
tendinopathy (jumper’s knee) and Achilles tendinopathy
[16-19], and avascular necrosis of the femoral head
[20-22]. ESWT has gained significant acceptance from
Europe (Germany, Austria, Italy and others) to South
America (Brazil, Columbia, Argentina and others), Asia
(Korea, Malaysia, Taiwan and others) and North America
(Canada and USA), and this had led to the change of Eur-
opean Society for Musculoskeletal Shockwave Therapy to
International Society for Musculoskeletal Shockwave
Therapy (ISMST) in 2000. In USA, FDA (Food and Drug
Administration) first approved the specific shockwave
device, OssaTron (High Medical Technology, Lengwil,
Switzerland, now Sanuwave/Alpharetta, GA) for the treat-
ment of proximal plantar fasciitis in 2000 and lateral epi-
condylitis of the elbow in 2003. FDA also approved Epos
(Dornier Medical System, Kennesaw, GA) for the treat-
ment of plantar fasciitis and Sonocur (Siemens Medical
Systems, Iselin, NJ) for the treatment of lateral epicondyli-
tis of the elbow in 2002, Orthospec (Medispec, German-
town, MD) and Orbasone (Orthometrix, White Plains,
NY) for the treatment of plantar fasciitis in 2005. In the
meantime, many off-label uses of ESWT were also studied
including calcific tendinitis of the shoulder, patellar tendi-
nopathy, Achilles tendinopathy, and non-union of long
bone fracture, avascular necrosis of the femoral head and
others. The vast majority of the published papers including
randomized control trials and cohort studies showed
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positive effects and evidence base medicine in favor of
ESWT [1-6,8-12,23]. However, a few studies reported that
ESWT is ineffective or less effective with the results com-
parable to the placebo effect [7,24,25], and this has stirred
up the debate and controversy. This article reviews the
current status of ESWT in the treatment of musculoskele-
tal disorders.
Principle of shockwave generation
There are three main techniques through which shock-
waves are generated. These are electrohydraulic, electro-
magnetic, and piezoelectric principles, and each of
which represents a different technique of generating
shockwaves. Electrohydraulic principle represents the
first generation of orthopedic shockwave machine. Elec-
trohydraulic shockwaves are high-energy acoustic waves
generated by the underwater explosion with high-voltage
electrode spark discharge, and the acoustic waves are
then focused with an elliptical reflector and targeted at
the diseased area to produce therapeutic effect [26]. It is
characterized by large axial diameters of the focal
volume and high total energy within that volume [27].
Shockwave generation through the electromagnetic
technique involves the electric current passing through
a coil to produce a strong magnetic field. A lens is used
to focus the waves, with the focal therapeutic point
being defined by the length of the focus lens. The
amplitude of the focused waves increases by non-linear-
ity when the acoustic wave propagates toward the focal
point [26,27] Shockwave of piezoelectric technique
involves a large number (usually > 1,000) of piezocrys-
tals mounted in a sphere and receives a rapid electrical
discharge that induces a pressure pulse in the surround-
ing water steepening to a shockwave. The arrangements
of the crystals cause self-focusing of the waves toward
the target center, and lead to an extremely precise
focusing and high-energy within a defined focal volume.
When comparing different shockwave devices, the
important parameters include pressure distribution,
energy density and the total energy at the second focal
point in addition to the principle of shockwave genera-
tion of each device.
Shockwave pattern differs from ultrasound wave that
is typically biphasic and has a peak pressure of 0.5 bar.
Shockwave pattern is uni-phasic with the peak pressure
as high as 500 bars [26]. In essence, the peak pressure
of shockwave is approximately 1,000 times that of ultra-
sound wave. There are two basic effects of shockwave.
The primary effect is the direct mechanical forces that
result in the maximal beneficial pulse energy concen-
trated at the target point where treatment is provided;
and the secondary effect is the indirect mechanical
forces by cavitation which may cause negative effect or
damage to the tissues [26-30].
Mechanism of shockwave therapy
The mechanism of shockwave therapy is not fully under-
stood. The most important physical parameters of shock-
wave therapy for the treatment of orthopedic disorders
include the pressure distribution, energy flux density and
the total acoustic energy. In contrast to lithotripsy in
which shockwaves disintegrate renal stones, orthopedic
shockwaves are not being used to disintegrate tissue, but
rather to microscopically cause interstitial and extracellu-
lar responses leading to tissue regeneration [26,27].
Animal experiments
Shockwave therapy for bone healing
Several studies had investigated the effects of shockwave
therapy on fracture healing and articular cartilage in ani-
mal experiments. Haupt et al in an experimental model in
rats, confirmed a positive effect of shockwave treatment
on fracture healing [31]. Johannes et al showed the promo-
tion of bony union with shockwave therapy in hyper-
trophic non-unions in dogs [32]. Wang et al demonstrated
that shock wave therapy enhanced callus formation and
induced cortical bone formation in acute fractures in dogs
and the effect of shockwave therapy appeared to be time-
dependent [33]. Forriol et al, however, reached an alterna-
tive conclusion and thought that shockwave treatment
might delay bone healing [34]. The conflicting results are
due different types of animals and different shockwave
dosages used. Wang et al had demonstrated that high-
energy shockwave therapy produces a significantly higher
bone mass including BMD (bone mineral density), callus
size, ash and calcium contents, and better bone strength
than the control group after fractures of the femurs in rab-
bits. The effects of low-energy shockwave therapy were
less prevailing with comparable results as compared to the
control. Therefore, the effect of shockwave therapy on
bone mass and bone strength appeared to be dose- and
time-dependent [35]. Many other studies also investigated
the effect of shockwave therapy on bone healing in ani-
mals. The important findings included superoxide med-
iates shockwave induction of ERK-dependent osteogenic
transcription factor (CBFA-1) and mesenchymal cells dif-
ferentiation toward osteoprogenitors [36]. Extracorporeal
shockwave promotes bone marrow stromal cell growth
and differentiation toward osteo-progenitors associated
with TGF-b1 and VEGF induction [37]. Physical shock-
wave mediates membrane hyperpolarization and Ras acti-
vation for osteogenesis in human bone marrow stromal
cells [38], Shockwave promotes bone regeneration by the
recruitment of mesenchymal stem cells and expressions of
TGF-b1 and VEGF [39].
Shockwave therapy for insertional tendinopathy
Many studies investigated the effect of shockwave ther-
apy on insertional tendinopathies. Rompe et al
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demonstrated dose-related effects of shockwave on rab-
bit tendo Achilles, and suggested that energy flux den-
sity of more than 0.28 mJ/mm2 should not be used
clinically in the treatment of tendon disorders [40]. In
their study, a statistically significant increase of capillary
formation was noted with higher energy shock wave
(0.60 mJ/mm2), which also caused more tissue reaction
and potential damage to the tendon tissue. Wang et al
had demonstrated that shockwaves enhance neovascu-
larization with formation of new capillary and muscular-
ized vessels at the tendon-bone junction of the Achilles
tendons in dogs [41]. In another study in rabbit model,
Wang et al further demonstrated that shockwave ther-
apy induces the ingrowth of neo-vessels (neovasculariza-
tion) including capillary and muscularized vessels than
the control at the tendon-bone junction. Shockwave
therapy releases angiogenetic growth and proliferating
factors including eNOS, VEGF, and PCNA [42]. The
eNOS and VEGF began to rise in as early as one week
and remained high for 8 weeks, then declined to base-
line in 12 weeks; whereas the increase of PCNA and
neo-vessels began in 1 weeks and persisted for 12 weeks
and longer. Therefore, the mechanism of shockwave
therapy may have involved the improvement in agnioge-
netic growth factors, which in turn induce neovasculari-
zation and improve blood supply at the tendon-bone
junction of the Achilles tendon in rabbits.
Chronic tendinopathy is an overuse syndrome mani-
fested with pain and tenderness due to mucoid and chon-
droid degeneration and formation of plump tenocytes
and increased fibroblastic and myofibroblastic cells and
absent inflammatory cells [43]. Some studies reported
that chronic painful tendinopathy exhibited increased
occurrence of sprouting nonvascular sensory, substance
P-positive nerve fibers and decreased occurrence of vas-
cular sympathetic nerve fibers, and suggested that the
altered sensory-sympathetic innervation may play a role
in the pathogenesis of tendinopathy [44]. It is believed
that shockwave therapy alleviates pain due to insertional
tendinopathy by the induction of neovascularization and
improvement of blood supply to the tissue, and initiating




Many studies investigated the effect of shockwave therapy
in the treatment of proximal plantar fasciitis and reported
a success rate ranging from 34% to 88% [1,45-62]. The
majority of the published papers reported a positive and
beneficial effect of ESWT in proximal plantar fasciitis.
Rompe et al suggested that three weekly treatments with
1,000 impulses of low-energy shockwave at 0.06 mJ/mm2
appear to be an effective therapy for plantar fasciitis with
significant alleviation of pain and improvement in function
[58]. Wang et al treated 79 patients (85 heels) with plantar
fasciitis including 59 women and 20 men with an average
age of 47 years (range 15-75 years) with shockwave ther-
apy. At one-year follow-up, the overall results were 75.3%
complaint free, 18.8% significantly better, 5.9% slightly bet-
ter and none unchanged or worse. The recurrent rate was
5% [60]. It was concluded that shockwave therapy is a safe
and effective modality in the treatment of proximal plantar
fasciitis.
In contrast, few studies reported the opposite results of
ESWT in the treatment of plantar fasciitis [7,24,25,63,64].
Buchbinder R et al compared 81 patients who received
ultrasound-guided ESWT given weekly for 3 weeks to a
total dose of at least 1,000 mJ/mm2 with 85 patients in the
placebo group who received treatment to a total dose of
6.0 mJ/mm2, and concluded that no evidence to support a
beneficial effect of ESWT over placebo on pain, function
and quality of life [24]. Haake M et al compared 135
patients allocated to ESWT with 137 patients allocated to
placebo and the results showed that ESWT is ineffective
in the treatment of chronic plantar fasciitis [64]. In a ran-
domised double blind control trial, Speed CA et al con-
cluded that no treatment effect of moderate dose of
ESWT in subjects with plantar fasciitis. Efficacy may be
highly dependent upon machine types and treatment pro-
tocol [25]. Therefore, controversy exists on the effect of
ESWT in the treatment of chronic plantar fasciitis. The
differences are probably due to the difference in methodol-
ogy of the study, the patient selection criteria, the use of
different devices, different energy levels and the total
energy and the outcome measurements.
Several studies compared the effect of ESWT with sur-
gery, local corticosteroid injection or physical therapy in
the treatment of proximal plantar fasciitis [62,65,66]. Sur-
gical treatment by plantar fasciotomy and ESWT showed
comparable functional outcomes, however, ESWT
incurred no surgical risks including surgical pain [62].
Physical therapy has shown to be comparable or better
effect than ESWT in proximal plantar fasciitis, however,
physical therapy is time consuming and inconvenient [63].
Corticosteroid injection shows better short-term effect,
but the long-term results favor ESWT [66].
The application of ESWT in proximal plantar fasciitis
is performed with either local anesthesia or no anesthe-
sia. Several reports showed that ESWT is less effective
when the treatment is performed with the use of local
anesthesia [67,68]. The majority of our patients were
treated with no local anesthesia. However, our observa-
tions failed to distinguish any difference between treat-
ment with or without local anesthesia. In case patient is
unable to tolerate the procedure because of pain during
treatment, the anesthesia with constant sedation can be
used.
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The complications of ESWT in proximal plantar fas-
ciitis are low and negligible. Local reddening, ecchymo-
sis, or mild hematoma, and migraine are among the list
of complications. The complications can be successfully
managed conservatively and spontaneous recovery is
anticipated.
In summary, the literature review unveiled discrepancy
and controversy on the effect of ESWT on proximal plan-
tar fasciitis. Many factors can influence the effects of
ESWT in the treatment of proximal plantar fasciitis. The
vast majority of the published papers are in favor of
ESWT. Additional studies are needed to validate the effec-
tiveness of ESWT in the treatment of proximal plantar
fasciitis.
Lateral epicondylitis of the elbow
Several studies investigated the effect of shockwave ther-
apy in patients with lateral epicondylitis of the elbow, and
the success rate ranged from 68% to 91% [69-75]. Rompe
et al reported good or excellent outcome in 48% and an
acceptable results in 42% at the final review at 24 weeks in
50 patients with chronic tennis elbow treated with 3,000
impulses of shockwave therapy compared with 6% and
24%, respectively, in the control patients treated with 30
impulses [76]. Wang et al compared the results of shock-
wave therapy in 57 patients (58 elbows) with lateral epi-
condylitis of the elbow with a control group of 6 patients
(6 elbows) with a follow-up of 12 to 26 months. The over-
all results of the treatment group were complaints free in
27 (61.4)%, significantly better in 13 (29.5)%, slightly better
in 3 (6.8%) and unchanged in 1 (2.3%). Recurrent pain of
lesser intensity was noted in 3 patients (6.8%). In the con-
trol group, however, the results were unchanged in all 6
patients [77]. Few studies reported no effect of ESWT or
less effect comparable to the placebo [78-83]. In a review
of 9 placebo-controlled trials, Buchbinder et al concluded
that there is “platinum” level that ESWT provides little or
no benefit in term of pain and function in lateral elbow
pain. There is “silver” level evidence that steroid injection
may be more effective than ESWT [7,78]. Haake et al in a
review of 20 studies concluded that no clinically relevant
efficacy has been proven for the use of ESWT for lateral
elbow pain [79,80]. Speed et al in a double blind rando-
mized trial concluded that there appears to be a significant
placebo effect of moderate dose of ESWT in subjects with
lateral epicondylitis, but there is no evidence of added ben-
efit of treatment when compared to sham therapy [82].
The differences were attributed to the patient selection,
the techniques, the manufacture devices, the use of local
anesthesia and the method of outcome measurements.
Calcifying tendinitis of the shoulder
The success rate of shockwave therapy in patients with
calcific tendinitis of the shoulder was reported ranging
from 78% to 91% [84-93]. Spindler et al reported com-
plete pain relief and full shoulder joint movement in
three patients two years after shockwave therapy, and a
fragmentation of calcification was achieved after 24 h
[12]. Wang et al compared the results of shockwave ther-
apy in 37 patients (39 shoulders) with calcific tendonitis
of the shoulder with a control group of 6 patients (6
shoulders). At 2- to 3-year follow-up, the overall results
of the shockwave group were complaints free in 60.6%,
significantly better in 30.3%, slightly better in 3.0% and
unchanged in 6.1%. Only two patients (6%) showed
recurrent pain of lesser intensity, and none showed
worse symptoms. The results of the control group were
slightly better in 1 (16.7%) and unchanged in 5 (83.3%).
Radiographs showed complete elimination of calcium
deposits in 57.6%, partial elimination or fragmentation in
15.1%, and unchanged in 27.3% for the shockwave group.
For the control group, the calcium deposit was fragmen-
ted in 1 (16.7%) and unchanged in 5 (83.3%). None
showed recurrence of calcium deposit 2 years after
shockwave therapy. There was a correlation of functional
improvement with the elimination of calcium deposit
[94]. Jurgowski and Loew treated patients with two ses-
sions of 2,000 impulses each of shockwave and reported
a marked reduction of symptoms with an average of 30%
improvement in the Constant score at the 12-week fol-
low-up. Radiographs showed complete elimination of the
calcification in seven patients, and partial elimination in
five patients. Magnetic resonance imaging did not show
any lasting damage to bone or soft tissue [95,96]. Rompe
et al reported significant improvement in 72.5% of the
patients and only six (15%) of 40 patients treated with
1,500 impulses of shockwaves reported no improvement.
Complete or partial disintegration of the calcium deposits
was observed in 62.5% of the patients [74]. In another
study, Rompe et al reported that shockwave therapy pro-
vides equal or better results than surgery in patients with
calcifying tendonitis of the shoulder [97].
Patellar tendinopathy (Jumper’s knee) and Achilles
tendinopathy
Several studies have reported favorable results of shock-
wave therapy in athletes with Jumper’s knee (patellar ten-
dinopathy) with the success rate ranged from 73.5% to
87.5% [16,19,43,98-100]. ESWT was also utilized in
patients with patellar tendinopathy secondary to harvest-
ing of the patellar tendon for ACL reconstruction. Wang
et al compared 30 knees in 27 patients treated with
ESWT with 24 knees in 23 patients treated conserva-
tively, the results at 2- to 3-year follow-up showed 43%
excellent, 47% good, 10% fair and none poor for the
study group, and none excellent, 50% good, 25% fair and
25% poor for the control group (P < 0.05). Ultrasono-
graphic examination showed a significant increase in the
vascularity of the patellar tendon and a trend of reduc-
tion in the patellar tendon thickness after ESWT as com-
pared to conservative treatments [43]. Peers KH et al
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compared 13 knees treated surgically with 15 knees
received ESWT, and reported a comparable functional
outcome in patient with patellar tendinopathy resistant
to conservative treatments [100]. It appears that ESWT is
effective in the management of patients with chronic
patellar tendinopathy.
Many studies investigated the effect of ESWT in
Achilles tendinopathy, and most reported favorable
results with similar success rate as patellar tendinopathy
[17,18,101-103]. Rompe et al compared 25 patients trea-
ted by eccentric stretching exercises with 25 patients
treated with repetitive ESWT, and the results showed
that eccentric loading is inferior to ESWT in the treat-
ment of patients with chronic recalcitrant Achilles ten-
dinopathy [101].
ESWT in bone disorders
Non-union and delayed union of long bone fracture
Several studies investigated the effect of shockwave ther-
apy for non-union and delayed union of long bone frac-
tures, and reported the success rate of achieving bony
union ranged from 50% to 85% [13,14,104-110]. Schaden
et al reported a success of 85% in the treatment of 115
delayed and non-unions [106]. Valchanou et al [107]
reported bony unions in 70 of 82 patients with delayed or
chronic nonunion of fractures at various locations. Vogel
et al reported a 60.4% union rate in 48 patients with pseu-
darthroses treated with 3,000 shockwave impulses [108].
Wang et al treated 72 patients with non-unions of long
bone fracture with shockwave therapy, and reported a suc-
cess rate of 82.4% bony union at 6-month follow-up [104].
Rompe et al reported a 50% success rate in the treatment
of delayed bone union with shockwaves in clinical study
[109], whereas Schleberger and Senge [110] showed suc-
cessful fracture healing in three of four pseudoarthroses
treated with 2000 impulses of shockwaves. Recently, Elster
EA et al reported an 80.2% success in 172 non-union of
the tibia [14]. The results of ESWT in non-union of long
bone appear to be comparable to surgical intervention.
However, the advantages of ESWT include no surgery
with no surgical pain and surgical risks.
AVNFH (Avascular necrosis of the femoral head) For
symptomatic hips affected by AVNFH, conservative
treatments are generally not successful, and surgery is
indicated with the type of surgery varying according to
the stage of the disease [111]. Core decompression with
or without bone grafting is considered the gold standard
of femoral head preserving procedures. However, the
results of core decompression varied widely and most
reports are unsatisfactory [112] ESWT was recently uti-
lized in the treatment of early AVNFH. Several articles
reported the positive effect of shockwave therapy for
AVNFH [21,22,113-116]. Wang et al compared 23
patients with 29 hips treated with ESWT and 25 patients
with 28 hips treated by core decompression with non-
vascularized fibular bone grafting, total hip arthroplasty
(THA) was performed in 3% and 21% (P = 0.039) in 1
year, 10% and 32% (P = 0.044) in 2 years and 24% and
64% (P = 0.002) in 8 to 9-year follow-up for the ESWT
group and the surgical group respectively. Significant
improvements in pain and function were noted at each
time intervals favoring the ESWT. There was a trend of
decrease in the size of the lesion in the ESWT group
[22,117]. In animal experiment in rabbits, ESWT was
shown to increase BMP-2 protein and mRNA, and up-
regulation of VEGF expression in necrotic subchondral
bone of the femoral head. The up-regulation of VEGF
may play a role inducing the ingrowth of neovasculariza-
tion and improvement in blood supply to the femoral
head [118,119]. These findings are in concert with our
findings with histopathological examination and immu-
nohistochemical analysis, ESWT was shown to promote
angiogenesis and bone remodeling and regenerative
effect in AVNFH [117]. It appears that ESWT is effective
in the retardation or prevention of collapse of the femoral
head in early AVNFH. The application of ESWT was also
found effective in the treatment of corticosteriod induced
AVNFH in patients with systemic lupus erythematosus
[114]. Wang et al compared 15 patients with 26 hips in
patients with systemic lupus erythematosus with the con-
trol of 24 patients with 29 hips, THA was performed in
12% and 14% respectively, and there were no difference
in pain and function. It is concluded that the response of
patients with SLE to ESWT for AVNFH is comparable to
AVNFH in non-SLE patients [114].
Other disorders Several studies reported a positive effect
of shockwave therapy in Peyronie’s disease and complex
regional pain syndrome (RSD or reflex sympathetic dystro-
phy) [120], osteoarthritis of the knee [121], spine fusion
[122], malignant cells [123,124], and gene therapy [125].
Furthermore, the application of ESWT has been expanded
to non-musculoskeletal diseases. Recent studies showed
that ESWT is effective in chronic diabetic foot ulcers
[126,127] and ischemic heart disease [128,129].
In conclusion, ESWT is a new non-invasive therapeutic
modality with effectiveness, convenience and safety.
ESWT has the potential of replacing surgery in many
orthopedic disorders without the surgical risks. The com-
plication rates are low and negligible. The exact mechan-
ism of shockwave therapy remains unknown. In animal
experiments, ESWT induces a cascade of biological
responses and molecular changes including the ingrowth
of neovascularization and up-regulation of angiogenetic
growth factors leading to the improvement in blood sup-
ply and tissue regeneration. There is a great potential for
translational research and development in the armamen-
tarium of extracorporeal shockwave technology.
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